{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T19:20:33Z","timestamp":1780514433530,"version":"3.54.1"},"reference-count":34,"publisher":"BMJ","issue":"6","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Sex Transm Infect"],"accepted":{"date-parts":[[2025,1,27]]},"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Human papillomavirus (HPV) is a very common sexually transmitted infection. Persistent infection with high-risk subtypes can lead to a variety of cancers. Men who have sex with men (MSM), particularly those who are living with HIV (MSMLWH), have a high prevalence of HPV infection and are at greatest risk of HPV-related diseases such as anal cancer. HPV vaccines are effective in preventing new infections, and many countries have implemented HPV vaccination for MSM.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This systematic review aimed to examine HPV vaccine uptake among MSM and MSMLWH. Quantitative studies published between 2010 and 2022 were screened and included if they detailed HPV vaccination uptake data for MSM and MSMLWH. Identified studies were screened using Covidence, data were extracted from the final included studies and narratively synthesised, and risk of bias of studies was assessed using the Joanna Briggs Institute Checklist tool for prevalence studies.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>There were 19 studies all from high-income countries, included in the final review. This review showed a wide variety of HPV vaccine uptake, ranging from 2.7% to 91.5% for HIV-negative MSM and among MSMLWH ranging from 5.6% to 90%. Although limited by the heterogeneity of studies and settings, there was evidence of a consistent, steady increase in HPV vaccination particularly among younger men. MSMLWH generally had higher rates of HPV vaccination, but overall HPV vaccine uptake remained suboptimal.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>MSMLWH are at high risk of HPV-related disease. Despite an available and efficacious vaccine in many countries, this review showed overall rates of HPV vaccination uptake remain inadequate. Further research and policy should aim to address and overcome barriers to HPV vaccination.<\/jats:p>\n                  <jats:p>PROSPERO registration number<\/jats:p>\n                  <jats:p>CRD42023382251.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/sextrans-2024-056361","type":"journal-article","created":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T13:20:45Z","timestamp":1740662445000},"page":"414-421","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Human papillomavirus vaccination uptake among men who have sex with men living with HIV"],"prefix":"10.1136","volume":"101","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2898-8789","authenticated-orcid":false,"given":"Conor","family":"Moran","sequence":"first","affiliation":[{"name":"Infectious Diseases\/Microbiology, Westmead Hospital, Westmead, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8841-5635","authenticated-orcid":false,"given":"Jaime","family":"Garcia-Iglesias","sequence":"additional","affiliation":[{"name":"Centre for Biomedicine, Self and Society, The University of Edinburgh Usher Institute of Population Health Sciences and Informatics, Edinburgh, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colm","family":"Kerr","sequence":"additional","affiliation":[{"name":"GUIDE, Department of GU Medicine and Infectious Diseases, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,2,27]]},"reference":[{"key":"2025082809551086000_101.6.414.1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.30716"},{"key":"2025082809551086000_101.6.414.2","unstructured":"P\u00e9rez-Plasencia C , Due\u00f1as-Gonzalez A , Bustos-Mart\u00ednez J . Activaci\u00f3n de La V\u00eda de Wnt\/Beta Catenina En El Proceso de Carcinogenesis Cervical. 4. Archivos de Medicina, 2008."},{"key":"2025082809551086000_101.6.414.3","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(12)70080-3"},{"key":"2025082809551086000_101.6.414.4","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir1012"},{"key":"2025082809551086000_101.6.414.5","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(21)02178-4"},{"key":"2025082809551086000_101.6.414.6","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djz219"},{"key":"2025082809551086000_101.6.414.7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0909537"},{"key":"2025082809551086000_101.6.414.8","doi-asserted-by":"publisher","DOI":"10.4161\/hv.29532"},{"key":"2025082809551086000_101.6.414.9","doi-asserted-by":"publisher","DOI":"10.1071\/SH16067"},{"key":"2025082809551086000_101.6.414.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2021.05.013"},{"key":"2025082809551086000_101.6.414.11","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.g7647","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation","volume":"349","author":"Shamseer","year":"2015","journal-title":"BMJ"},{"key":"2025082809551086000_101.6.414.12","unstructured":"Joanna Briggs Institute . Checklist for prevalence studies. 2017. Available: http:\/\/joannabriggs.org\/research\/critical-appraisal-tools.htmlwww.joannabriggs.org"},{"key":"2025082809551086000_101.6.414.13","doi-asserted-by":"crossref","first-page":"5413","DOI":"10.1080\/21645515.2021.1979379","article-title":"Human papillomavirus (HPV) vaccination across a cascade of knowledge, willingness, and uptake among gay, bisexual, and other men who have sex with men in Canada\u2019s three largest cities","volume":"17","author":"Grewal","year":"2021","journal-title":"Hum Vaccin Immunother"},{"key":"2025082809551086000_101.6.414.14","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0000000000001008"},{"key":"2025082809551086000_101.6.414.15","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2020-054871"},{"key":"2025082809551086000_101.6.414.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2022.05.019"},{"key":"2025082809551086000_101.6.414.17","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2021.26.50.2001965","article-title":"Low vaccination coverage for human papillomavirus disease among young men who have sex with men, France, 2019","volume":"26","author":"Ortu","year":"2021","journal-title":"Euro Surveill"},{"key":"2025082809551086000_101.6.414.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2020.106329"},{"key":"2025082809551086000_101.6.414.19","doi-asserted-by":"publisher","DOI":"10.21037\/tcr.2016.10.66"},{"key":"2025082809551086000_101.6.414.20","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2018-053923"},{"key":"2025082809551086000_101.6.414.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2014.09.033"},{"key":"2025082809551086000_101.6.414.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2020.08.040"},{"key":"2025082809551086000_101.6.414.23","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2019.1675456"},{"key":"2025082809551086000_101.6.414.24","doi-asserted-by":"publisher","DOI":"10.1097\/CCO.0000000000000211"},{"key":"2025082809551086000_101.6.414.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.12.017"},{"key":"2025082809551086000_101.6.414.26","unstructured":"JCVI statement on a one-dose schedule for the routine hpv immunisation programme. 2022. Available: https:\/\/www.gov.uk\/government\/publications\/single-dose-of-hpv-vaccine-jcvi-concluding-advice\/jcvi-statement-on-a-one-dose-schedule-for-the-routine-hpv-immunisation-programme"},{"key":"2025082809551086000_101.6.414.27","doi-asserted-by":"publisher","DOI":"10.1177\/0956462419897514"},{"key":"2025082809551086000_101.6.414.28","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2014.302095"},{"key":"2025082809551086000_101.6.414.29","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2016.1151588"},{"key":"2025082809551086000_101.6.414.30","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2020.1846399"},{"key":"2025082809551086000_101.6.414.31","doi-asserted-by":"crossref","DOI":"10.1177\/1073274818780368","article-title":"Anal Cancer Prevention Perspectives Among Foreign-Born Latino HIV-Infected Gay and Bisexual Men","volume":"25","author":"Koskan","year":"2018","journal-title":"Cancer Control"},{"key":"2025082809551086000_101.6.414.32","doi-asserted-by":"crossref","first-page":"S370","DOI":"10.1097\/QAI.0000000000001413","article-title":"Increasing Human Papillomavirus Vaccine Coverage Among Men Who Have Sex With Men-National HIV Behavioral Surveillance, United States, 2014","volume":"75 Suppl 3","author":"Oliver","year":"2017","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2025082809551086000_101.6.414.33","doi-asserted-by":"publisher","DOI":"10.1007\/s13178-022-00740-9"},{"key":"2025082809551086000_101.6.414.34","doi-asserted-by":"crossref","unstructured":"Page MJ , Moher D , Bossuyt PM , et al . PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ 2021;372. doi:10.1136\/bmj.n160","DOI":"10.1136\/bmj.n160"}],"container-title":["Sexually Transmitted Infections"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/sextrans-2024-056361","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T13:03:41Z","timestamp":1759928621000},"score":1,"resource":{"primary":{"URL":"https:\/\/sti.bmj.com\/lookup\/doi\/10.1136\/sextrans-2024-056361"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,27]]},"references-count":34,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,8,28]]},"published-print":{"date-parts":[[2025,9]]}},"alternative-id":["10.1136\/sextrans-2024-056361"],"URL":"https:\/\/doi.org\/10.1136\/sextrans-2024-056361","relation":{},"ISSN":["1368-4973","1472-3263"],"issn-type":[{"value":"1368-4973","type":"print"},{"value":"1472-3263","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,27]]}}}